Compounds > durapatite
Page last updated: 2024-08-21

durapatite and rifapentine

durapatite has been researched along with rifapentine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF1
Jiang, D; Liu, Y1
Jiang, D; Liu, Y; Zhu, J1
Jiang, D; Liang, Q; She, S; Song, X; Wang, C; Wang, Z1

Other Studies

4 other study(ies) available for durapatite and rifapentine

ArticleYear
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus

2015
Effect of bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres on bone and joint tuberculosis in vitro.
    Cell biology international, 2017, Volume: 41, Issue:4

    Topics: Cell Differentiation; Cell Line, Tumor; Drug Carriers; Durapatite; Humans; Lactic Acid; Microbial Sensitivity Tests; Microspheres; Mycobacterium tuberculosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Tuberculosis, Osteoarticular; Wnt Signaling Pathway

2017
Release characteristics of bone‑like hydroxyapatite/poly amino acid loaded with rifapentine microspheres in vivo.
    Molecular medicine reports, 2017, Volume: 16, Issue:2

    Topics: Alanine Transaminase; Amino Acids; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Bone and Bones; Creatinine; Disease Models, Animal; Durapatite; Male; Microspheres; Organ Specificity; Rabbits; Rifampin

2017
Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Adipocytes; Animals; Antitubercular Agents; Calcium Phosphates; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Durapatite; Female; Microspheres; Particle Size; Rabbits; Rifampin; Structure-Activity Relationship; Surface Properties

2019